Article info

Download PDFPDF
Research paper
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study

Authors

  1. Correspondence to Professor Felix Rosenow, Epilepsy Center Hessen, Department of Neurology, University Hospitals Giessen & Marburg, Baldingerstrasse, 35043 Marburg, Germany; rosenow{at}med.uni-marburg.de
View Full Text

Citation

Rosenow F, Schade-Brittinger C, Burchardi N, et al
The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study

Publication history

  • Received December 8, 2011
  • Revised February 22, 2012
  • Accepted February 27, 2012
  • First published May 17, 2012.
Online issue publication 
October 08, 2012

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.